Prognostication in Advanced Cancer: A Study Examining an Inflammation-Based Score

Oxenham, 1998, Accuracy of prediction of survival by different professional groups in a hospice, Palliat Med, 12, 117, 10.1191/026921698672034203 Glare, 2003, A systematic review of physicians' survival predictions in terminally ill cancer patients, BMJ, 327, 195, 10.1136/bmj.327.7408.195 Christakis, 2000, Extent and determinants of error in doctors' prognoses in terminally ill patients: prospective cohort study, BMJ, 320, 469, 10.1136/bmj.320.7233.469 National Confidential Enquiry into Patient Outcome and Death (NCEPOD), 2008 Lau, 2007, A systematic review of prognostic tools for estimating survival time in palliative care, J Palliat Care, 23, 93, 10.1177/082585970702300205 Mantovani, 2009, Cancer: inflaming metastasis, Nature, 457, 36, 10.1038/457036b Mantovani, 2008, Cancer-related inflammation, Nature, 454, 436, 10.1038/nature07205 McMillan, 2009, Systemic inflammation, nutritional status and survival in patients with cancer, Curr Opin Clin Nutr Metab Care, 12, 223, 10.1097/MCO.0b013e32832a7902 Roxburgh, 2010, Role of systemic inflammatory response in predicting survival in patients with primary operable cancer, Future Oncol, 6, 149, 10.2217/fon.09.136 Forrest, 2004, Comparison of an inflammation-based prognostic score (GPS) with performance status (ECOG) in patients receiving platinum-based chemotherapy for inoperable non-small-cell lung cancer, Br J Cancer, 90, 1704, 10.1038/sj.bjc.6601789 Crumley, 2006, Evaluation of an inflammation-based prognostic score in patients with inoperable gastro-oesophageal cancer, Br J Cancer, 94, 637, 10.1038/sj.bjc.6602998 Roxburgh, 2009, Comparison of the prognostic value of inflammation-based pathologic and biochemical criteria in patients undergoing potentially curative resection for colorectal cancer, Ann Surg, 249, 788, 10.1097/SLA.0b013e3181a3e738 Roxburgh, 2010, Comparison of the prognostic value of tumour and patient related factors in patients undergoing potentially curative surgery for colon cancer, Colorectal Dis, 12, 987, 10.1111/j.1463-1318.2009.01961.x Proctor, 2011, An inflammation-based prognostic score (mGPS) predicts cancer survival independent of tumour site: a Glasgow Inflammation Outcome Study, Br J Cancer, 104, 726, 10.1038/sj.bjc.6606087 Wigmore, 1997, Down-regulation of the acute-phase response in patients with pancreatic cancer cachexia receiving oral eicosapentaenoic acid is mediated via suppression of interleukin-6, Clin Sci (Lond), 92, 215, 10.1042/cs0920215 Falconer, 1995, Acute-phase protein response and survival duration of patients with pancreatic cancer, Cancer, 75, 2077, 10.1002/1097-0142(19950415)75:8<2077::AID-CNCR2820750808>3.0.CO;2-9 Earle, 2004, Trends in the aggressiveness of cancer care near the end of life, J Clin Oncol, 22, 315, 10.1200/JCO.2004.08.136 O'Brien, 2006, Mortality within 30 days of chemotherapy: a clinical governance benchmarking issue for oncology patients, Br J Cancer, 95, 1632, 10.1038/sj.bjc.6603498 Steinhauser, 2000, Factors considered important at the end of life by patients, family, physicians, and other care providers, JAMA, 284, 2476, 10.1001/jama.284.19.2476 Clark, 2003, Freedom from unpleasant symptoms is essential for a good death, BMJ, 327, 180, 10.1136/bmj.327.7408.180-b MacDonald, 2006, Prognostic value of baseline inflammatory markers in inoperable non-small cell lung cancer (NSCLC), J Clin Oncol, 24, 17035, 10.1200/jco.2006.24.18_suppl.17035 Gripp, 2007, Survival prediction in terminally ill cancer patients by clinical estimates, laboratory tests, and self-rated anxiety and depression, J Clin Oncol, 25, 3313, 10.1200/JCO.2006.10.5411 Suh, 2007, Lactate dehydrogenase as a prognostic factor for survival time of terminally ill cancer patients: a preliminary study, Eur J Cancer, 43, 1051, 10.1016/j.ejca.2007.01.031 Martin, 2010, Prognostic factors in advanced cancer patients: use of patient-generated subjective global assessment in survival prediction, J Clin Oncol, 28, 4376, 10.1200/JCO.2009.27.1916 Glare, 2008, Predicting survival in patients with advanced disease, Eur J Cancer, 44, 1146, 10.1016/j.ejca.2008.02.030 Gagnon, 2010, Flexible modeling improves assessment of prognostic value of C-reactive protein in advanced non-small cell lung cancer, Br J Cancer, 102, 1113, 10.1038/sj.bjc.6605603 Roxburgh, 2011, Relationship between preoperative comorbidity, systemic inflammatory response, and survival in patients undergoing curative resection for colorectal cancer, Ann Surg Oncol, 18, 997, 10.1245/s10434-010-1410-8 Selawry, 1979, The individual and the median, 39 Smith, 1998, Telling the truth about terminal cancer, JAMA, 279, 1746, 10.1001/jama.279.21.1746